Thông tin tài liệu
| Nhan đề : |
| Evolution of treatment patterns and survival outcomes in patients with advanced non-small cell lung cancer treated at Frankfurt University Hospital in 2012–2018 |
| Tác giả : |
| Andrea, Wolf Jan A., Stratmann Shabnam, Shaid |
| Năm xuất bản : |
| 2023 |
| Nhà xuất bản : |
| Springer |
| Tóm tắt : |
| Immune checkpoint inhibitors (ICIs) have improved outcomes for patients with advanced non-small cell lung cancer (NSCLC) versus chemotherapy in clinical trials. In Germany, ICIs have been used clinically since 2015 for patients with advanced/metastatic NSCLC without epidermal growth factor receptor (EGFR)/anaplastic lymphoma kinase (ALK) aberrations. As part of I-O Optimise, a multinational research program utilizing real-world data on thoracic malignancies, we describe real-world treatment patterns and survival following reimbursement of ICIs for advanced NSCLC in Germany. |
| Mô tả: |
| CC BY |
| URI: |
| https://link.springer.com/article/10.1186/s12890-022-02288-1 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7262 |
| Bộ sưu tập |
| OER- Y học- Điều dưỡng |
XEM MÔ TẢ
112
XEM TOÀN VĂN
174
Danh sách tệp tin đính kèm: